• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:惠毅,魏海梁,闫曙光,李京涛,史捷.血管活性肠肽对肺泡巨噬细胞M1/M2型极化及相关细胞因子的影响[J].中国现代应用药学,2021,38(17):2053-2059.
HUI Yi,WEI Hailiang,YAN Shuguang,LI Jingtao,SHI Jie.Effects of Vasoactive Intestinal Peptide on M1/M2 Polarization and Related Cytokines in Alveolar Macrophages[J].Chin J Mod Appl Pharm(中国现代应用药学),2021,38(17):2053-2059.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1585次   下载 820 本文二维码信息
码上扫一扫!
分享到: 微信 更多
血管活性肠肽对肺泡巨噬细胞M1/M2型极化及相关细胞因子的影响
惠毅1, 魏海梁2, 闫曙光1, 李京涛3, 史捷4
1.陕西中医药大学基础医学院, 陕西 咸阳 712046;2.陕西中医药大学附属医院普外科, 陕西 咸阳 712000;3.陕西中医药大学附属医院感染科, 陕西 咸阳 712000;4.陕西中医药大学附属医院呼吸科, 陕西 咸阳 712000
摘要:
目的 观察血管活性肠肽(vasoactive intestinal peptide,VIP)对肺泡巨噬细胞(alveolar macrophages,AM) M1/M2极化和相关细胞因子的影响。方法 分别采用脂多糖(lipopolysaccharide,LPS)联合γ-干扰素(interferon-γ,IFN-γ)、白细胞介素-4(interleukin 4,IL-4)联合白细胞介素-13(interleukin 13,IL-13)诱导AM M1/M2型极化,后用10-8~10-6 mol·L-1 VIP干预极化的AM,免疫荧光双标法测定M1型AM标记物CD86和促炎因子白细胞介素-6(interleukin 6,IL-6)的共表达,M2型AM标记物CD206和抗炎因子白细胞介素-10(interleukin 10,IL-10)的共表达;ELISA检测细胞上清中IL-6、肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)、IL-10、精氨酸酶-1(arginase-1,Arg-1)的表达,RT-PCR检测巨噬细胞表面标记物CD86、CD206和巨噬细胞相关因子IL-6、TNF-α、诱导型一氧化氮合酶(inducible nitric oxide synthase,iNOS)、IL-10、Arg-1、几丁质酶-3样蛋白3(chitinase 3-like 3,Ym1)的表达。结果 经LPS联合IFN-γ、IL-4联合IL-13诱导后,AM分别向M1/M2型极化,与M1型相关的促炎因子IL-6、TNF-α、iNOS和与M2型相关的抗炎因子IL-10、Arg-1、Ym1的激活和释放明显高于未经诱导的正常组(P<0.05);不同浓度VIP (10-8~10-6 mol·L-1)的干预,均可下调M1型AM和相关炎症因子IL-6、TNF-α、iNOS的活性和表达(P<0.05);上调M2型AM和相关抗炎因子IL-10、Arg-1、Ym1的活性和表达(P<0.05)。结论 VIP可抑制AM M1型极化,减少炎症因子IL-6、TNF-α、iNOS的激活和释放;促进AM M2型极化,提高抗炎因子IL-10、Arg-1、Ym1的激活和释放,提示VIP在肺内炎症时可能通过调控AM M1/M2型极化,抑制炎症反应,对肺组织起保护性作用。
关键词:  血管活性肠肽  肺泡巨噬细胞  M1/M2型巨噬细胞极化  炎症因子
DOI:10.13748/j.cnki.issn1007-7693.2021.17.002
分类号:R966
基金项目:国家自然科学基金项目(81703974);陕西中医药大学学科创新团队建设项目(2019-YL05)
Effects of Vasoactive Intestinal Peptide on M1/M2 Polarization and Related Cytokines in Alveolar Macrophages
HUI Yi1, WEI Hailiang2, YAN Shuguang1, LI Jingtao3, SHI Jie4
1.College of Basic Medicine, Shaanxi University of Chinese Medicine, Xianyang 712046, China;2.Department of General Surgery, The Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712000, China;3.Department of Infectious Disease, The Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712000, China;4.Department of Respiratory, The Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712000, China
Abstract:
OBJECTIVE To observe the effects of vasoactive intestinal peptide(VIP) on M1/M2 polarization and related cytokines of alveolar macrophages(AM). METHODS Lipopolysaccharide(LPS) combined with interferon-γ(IFN-γ) and interleukin-4(IL-4) combined with interleukin-13(IL-13) were used to induce M1/M2 type polarization of AM, and then VIP (10-8-10-6 mol·L-1) was used to intervene the polarization of AM. The co-expression of M1 type AM marker CD86 and pro-inflammatory factor interleukin 6(IL-6) and co-expression of M2-type AM marker CD206 and anti-inflammatory factor interleukin 10(IL-10) was determined by immunofluorescence double standard method. Expression of IL-6, tumor necrosis factor-α(TNF-α), IL-10 and arginase-1(Arg-1) in cell supernatant was detected by ELISA. The macrophage surface markers CD86, CD206 and macrophage related factors IL-6, TNF-α, inducible nitric oxide synthase(iNOS), IL-10, Arg-1 and chitinase 3-like 3(Ym1) were detected by RT-PCR. RESULTS After induction by LPS combined with IFN-γ and IL-4 combined with IL-13, AM was polarized to M1/M2 type respectively. The activation and release of pro-inflammatory factors IL-6, TNF-α and iNOS related to M1 and anti-inflammatory factors IL-10, Arg-1 and Ym1 related to M2 were significantly higher than those in the uninduced normal group(P<0.05). Interference with different concentrations of VIP(10-8-10-6 mol·L-1) could down-regulate the activity and expression of M1 type AM and related inflammatory cytokines IL-6, TNF-α and iNOS(P<0.05). The activity and expression of M2 type AM and related anti-inflammatory factors IL-10, Arg-1 and Ym1 were up-regulated(P<0.05). CONCLUSION VIP can inhibit AM M1-type polarization and reduce the activation and release of inflammatory cytokines IL-6, TNF-α and iNOS. It can promote AM M2-type polarization and increase the activation and release of anti-inflammatory factors IL-10, Arg-1 and Ym1, suggesting that VIP may inhibit the inflammatory response and play a protective role in lung tissue by regulating the M1/M2-type polarization of AM in the process of pulmonary inflammation.
Key words:  vasoactive intestinal peptide  alveolar macrophages  polarization of M1/M2 macrophages  inflammatory cytokines
扫一扫关注本刊微信